10 withdrawn. 10 Phase 2, 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Withdrawn 10 |
| Phase 1 | 4 | Withdrawn 4 |
Follow Mycoses: new trials by email Literature Review of Mycoses trials Research Report on Mycoses
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South Africa VPM1002 Vaccine, BCG Vaccine, Placebo - Tuberculosis, HIV Infections | Phase 1 / Phase 2 | Withdrawn | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 2026-12-31 | 2026-08-17 | |
| Efficacy and Safety of Different Doses of Venus Association in Patients With Vulvovaginal Candidiasis. Venus 20 + 0,064, Venus 20 + 1, Venus 20 + 4 - Vulvovaginal Candidiasis | Phase 2 | Withdrawn | EMS | 2022-07-01 | 2022-08-10 | |
| SUBA-Itraconazole Therapy for Coccidioidomycosis Refractory or Intolerant to Fluconazole SUBA-itraconazole - Coccidioidomycosis, Valley Fever | Phase 2 | Withdrawn | George R Thompson | 2021-05-15 | 2021-07-19 | |
| Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis Oral Encochleated Amphotericin B (CAMB) - Vulvovaginal Candidiases, Yeast Infection | Phase 2 | Withdrawn | Matinas BioPharma Nanotechnologies, Inc. | 2019-12-01 | 2019-03-08 | |
| Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients F901318, Caspofungin - Pulmonary Aspergillosis - Invasive, Acute Myeloid Leukemia | Phase 1 / Phase 2 | Withdrawn | F2G Ltd | 2017-04-20 | 2018-02-15 | |
| Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis Sertraline - Coccidioidomycosis | Phase 2 | Withdrawn | University of California, San Francisco | 2016-11-01 | 2022-03-21 | |
| Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive Aspergillosis Voriconazole, micafungin - Aspergillosis | Phase 2 | Withdrawn | University of Arkansas | 2011-02-01 | 2012-04-20 | |
| Safety of hLF1-11 for the Treatment of Infectious Complications Among HSCT Recipients human lactoferrin (hLF1-11) - Fungal Infection, Bacterial Infection | Phase 1 / Phase 2 | Withdrawn | AM-Pharma | 2008-11-01 | 2015-06-30 | |
| A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Proven Candidaemia hLF1-11, Placebo - Candidaemia | Phase 1 / Phase 2 | Withdrawn | AM-Pharma | 2008-07-01 | 2015-06-30 | |
| Safety and Efficacy of NAFT900 in Children With Tinea Capitis Naftifine hydrochloride foam, 3%, Vehicle - Tinea Capitis | Phase 2 | Withdrawn | Merz North America, Inc. | 2016-09-09 |
Candidiasis, Vulvovaginal (2) · Coccidioidomycosis (2) · Aspergillosis (1) · Bacterial Infections (1) · Candidemia (1) · Cellulitis (1) · HIV Infections (1) · Infections (1) · Invasive Pulmonary Aspergillosis (1) · Leukemia, Myeloid, Acute (1) · Neutropenia (1) · Tinea Capitis (1) · Torulopsis (1) · Tuberculosis (1)
Bacterial Infections and Mycoses (10) · Infections (9) · Candidiasis (3) · Genital Diseases (3) · Urogenital Diseases (3) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases, Female (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Inflammation (2) · Invasive Fungal Infections (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2)
BCG Vaccine (1) · Caspofungin (1) · Itraconazole (1) · Micafungin (1) · Sertraline (1) · VPM1002 recombinant BCG vaccine (1) · Voriconazole (1) · butoconazole (1) · lactoferrin (1-11), human (1) · olorofim (1)
AM-Pharma (2) · EMS (1) · F2G Ltd (1) · George R Thompson (1) · International Maternal Pediatric Adolescent AIDS Clinical Trials Group (1) · Matinas BioPharma Nanotechnologies, Inc. (1) · Merz North America, Inc. (1) · University of Arkansas (1) · University of California, San Francisco (1)
United States (3) · Netherlands (2) · South Africa (1)
Elias Anaissie, MD (1) · George R Thompson, MD (1) · Lisa Marie Cranmer, MD, MPH (1) · Michael Kuligowski, MD (1) · Oliver Cornely, PhD, MD (1) · Peter J Donnelly, PhD (1) · Professor P.E. Verweij, MD, PhD (1) · Simon Paul, MD (1)
UM1AI068616 (1), UM1AI068632 (1), UM1AI106716 (1)